Sanjit Roy Chowdhary

Stay Healthy & Happy

[Sanjit Roy Chowdhary @sanjitrc06]

@DrArunKValsan @AmritaHospitals @ajay_duseja @drnipunverma @drsuniltaneja @RoyAHep @SaurabhMishraMD @doc_arka @AnandVKulkarni2 @DrLoomba @drbabupgi @RohitMehtaniDM @DharJahnvi @JasmohanBajaj @drvishal82 @RajivJalan1 Congratulations @DrArunKValsan

[Sanjit Roy Chowdhary @sanjitrc06]

@ajay_duseja @RadhaKDhiman @HepatologyPGI @dpgi_chandigarh Proud moment for Indian Hepatologist. Congratulations @RadhaKDhiman 🫡

[Sanjit Roy Chowdhary @sanjitrc06]

#Saroglitazar (Bilypsa) regulate the root cause in the management of #NASH & #metabolic health👍🏾

[VCU Stravitz-Sanyal Institute for Liver Disease @VCU_Liver]

In press: Saroglitazar improves nonalcoholic fatty liver disease and metabolic health in #liver transplant recipients, @ArunJSanyalVCU and the institute's Dr. M. Shadab Siddiqui & @VCU colleagues. https://t.co/pyvAvzOc2X #LiverTwitter @VCUTransplant

[Sanjit Roy Chowdhary @sanjitrc06]

#Saroglitazar earlier inclusion in #INASL guideline in India & now in #Yamada Text book of Gastroenterology in #NASH management #NASH #MASH #SLD

[NASH24x7 @nash24x7]

#Saroglitazar is now mentioned in, Yamada’s Textbook of Gastroenterology : the gastro bible universally respected across the globe.
#NAFLD #NASH #MASH #MAFLD #SLD #FattyLiverDisease

[Sanjit Roy Chowdhary @sanjitrc06]

Expressing my views on ET India Pharma World Awards @ETNOWlive @ETHealthWorld @ZydusUniverse

[ETHealthWorld @ETHealthWorld]

Join us at #ETREPharma and hear from @sanjitrc06, Vice President & Cluster Head, @ZydusUniverse

Link- https://t.co/19ovBb2v0I

#healthcareworkers #conference #IPWA #ETHealthWorld #Health #Pharma #Medical #Summit #Awards #healthcare #IndiaPharmaAwards

https://t.co/8p2iAcE0cQ

[Sanjit Roy Chowdhary @sanjitrc06]

@parulsood Congratulations 👏🏽👏🏽👏🏽Keep doing good work 👌🏾👍🏾

[Sanjit Roy Chowdhary @sanjitrc06]

#INASL2022 #ICOND @INASL_Liver @AjayDuseja @shivaramsingh @doc_arka @GlobalLiver @nash

[NASH24x7 @nash24x7]

#INASL2022 #ICOND @INASL_Liver @AjayDuseja @shivaramsingh @doc_arka

[Sanjit Roy Chowdhary @sanjitrc06]

@JM_Scindia @AAI_Official Given the scenic beauty of Bagdogra & massive tourist influx, Airport still continues to have poor infrastructure. Total chaos inside the airport, leading to extreme overcrowding! Limited progress in last 15yrs. Needs urgent revamping & capacity building

[Sanjit Roy Chowdhary @sanjitrc06]

@PrabirJha @ZydusUniverse Indeed!

[Sanjit Roy Chowdhary @sanjitrc06]

Awareness amongst community in asymptomatic diseases needs long term efforts & investment. NAFLD & NASH is such asymptomatic disease. Happy to see such acknowledgment happening. @nash24x7 @NashTagConf @INASL_Liver @ZydusUniverse @KowdleyMd @LiverSaver @NAFLDSupport @iDiacare

[IHW Council @IHWCouncil]

Zydus Life Sciences deserves the highest commendation for earning recognition for ‘Patient Centricity in Non-Communicable Diseases’ at #PatientFirstAwards. @ZydusUniverse @nash24x7

[Sanjit Roy Chowdhary @sanjitrc06]

Business success mantra. The 24/48 rule. #marketing #success

[Sanjit Roy Chowdhary @sanjitrc06]

Liver is the powerhouse organ which keep U healthy & hearty. Liver Healthy keeps U Healthy. #Liver #LiverDay #liverhealth #Nash #NAFLD #Patientsfirst #zyduslifescience #zydus #ZYDUSLIFE

[Zydus Lifesciences Ltd. @ZydusUniverse]

A healthy liver is the key to good health, this World Liver Day, we are inspired to go an extra mile to support you and your Liver. #ZydusLifesciences #DedicatedToLife #YouInspireUs #Zydus #ScienceHealthandInnovation #Science #Health #Innovation #liver #worldliverday

[Sanjit Roy Chowdhary @sanjitrc06]

#IndiaNAFLDReadiness , India policy readiness ahead in path & in Implementation of National NAFLD Policy as part of NPCDCS Guidelines @MoHFW_INDIA @NITIAayog @mansukhmandviya #DrShivsarin @INASL @AASLDtweets @EASLEUAffairs

[NASH24x7 @nash24x7]

India is one of the very few countries globally to have a #NAFLDPolicy , thanks to the collaborative efforts of Dr #ShivSarin, @MoHFW_INDIA and @NITIAayog. #DrSarin talks on the implementation of #NAFLDPolicy at #NAFLDConclave2022 @INASL_Liver @AASLDtweets @GlobalLiver @EASLnews

[Sanjit Roy Chowdhary @sanjitrc06]

#IBS is a very common in the India 🇮🇳 with a significant impact in the quality of life! It affect #women twice as much as men. Visbiome is available now in India 🇮🇳 Learn how #visbiome #probiotics #livingwithibs

[Visbiome @Visbiome]

#IBS is a very common disorder affecting ~15% of people in the US, with a significant impact in the quality of life! It affect #women twice as much as men. Learn how #visbiome #probiotics can help https://t.co/ETWtuqFJ7g
#internationalwomenday #livingwithibs

[Sanjit Roy Chowdhary @sanjitrc06]

This #WorldObesityDay let’s win the battle against #NAFLD & #NASH. To know more visit https://t.co/pWLjS5Qn2Q @WorldObesityDay @GLOBE_obesity @WorldObesity @ZydusUniverse @INASL_Liver @EASLnews @AASLDtweets @GlobalLiver

[NASH24x7 @nash24x7]

This #WorldObesityDay let’s win the battle against #NAFLD & #NASH. Visit https://t.co/0p4L01O88J to know more about this silent disease @WorldObesityDay @GLOBE_obesity @WorldObesity @ZydusUniverse @INASL_Liver @EASLnews @AASLDtweets @GlobalLiver

[Sanjit Roy Chowdhary @sanjitrc06]

Congratulations to ICON-D Team. @nagachalasani @nash24x7 @NashTagConf @ajay_duseja @DrKaushalMadan1 @NO_hep @NAFLDSupport @EASD_NAFLD @NAFLDSupport @NAFLDresearch @sanyalbio @shivaramsingh

[Ajay Duseja @ajay_duseja]

- Thanks to all co-investigators of - Indian Consortium on NAFLD (ICON-D)
- Largest real-life NAFLD data from south-Asia
- > 4000 patients
- 1/3rd significant fibrosis
- 10% cirrhosis
- Follow up- Hepatic/Extra-hepatic events more common in cirrhosis
https://t.co/LwKFK3i4tV

[Sanjit Roy Chowdhary @sanjitrc06]

Be a #Liver the powerhouse organ 👍🏾

[Ajay Duseja @ajay_duseja]

It's LIVER all the Way..
Not only Medically but also Philosophically. ..
I Love ❤ LIVER..

[Visbiome @Visbiome]

While many of us have heard about Ulcerative colitis (UC) or Chrohn's disease, many do not fully understand them. In the Crohn's & Colitis Awareness Week, follow the @CrohnsColitisFn to learn what they want others to know about these diseases. #CCAwarenessWeek #IBDVisible

[Visbiome @Visbiome]

Now that the weather is getting cold, a warm cup of coffee is all our spirit needs to warm itself. Medical News Today has published an article about how coffee drinkers may have a healthier gut microbiome!

Reminder: Don't mix Visbiome with anything hot!
https://t.co/kLUKTLXVuO

[Sanjit Roy Chowdhary @sanjitrc06]

Saroglitazar first patient for the phase 2b trial for NASH, started under authorization from USFDA 🇺🇸
@INASL_Liver @AASLDtweets @EASLnews @APASLnews

[NASH24x7 @nash24x7]

https://t.co/602B0zis6N

Another global update on Saroglitazar ! 😊

The first patient has been randomised for the phase 2b trial for NASH , being carried out under authorization from USFDA
@INASL_Liver @AASLDtweets @EASLnews @APASLnews